Hospitalisation cost for paediatric osteomyelitis and septic arthritis in New Zealand

Sarah Hunter,Zanazir Alexander,Haemish Crawford,Braden Te Ao,Vanessa Selak,John Mutu‐Grigg,Paula Lorgelly,Cameron Grant
DOI: https://doi.org/10.1111/jpc.16711
2024-10-28
Journal of Paediatrics and Child Health
Abstract:Aim Hospitalisation rates for paediatric bone and joint infection (BJI) in New Zealand (NZ) are among the highest globally. This study aims to quantify hospitalisation costs of BJI in 2018–2019. Methods National hospitalisation data from the NZ Ministry of Health was used to describe costs associated with all paediatric hospitalisations coded for osteomyelitis or septic arthritis in those aged <16 years. Data included age, ethnic group, area level deprivation, diagnosis‐related‐group coding, admission length and cost‐weight. Readmissions up to 24 months following the initial encounter were analysed for associated costs. Results More than ten million dollars was spent on hospitalisation for paediatric BJI over the study period (NZ 1 196 640 within 24 months following diagnosis. Higher median hospitalisation costs occurred for children residing in the most deprived versus least deprived neighbourhoods (NZ 9010, P
pediatrics
What problem does this paper attempt to address?